EventsThe 20th International Electronic Conference on Synthetic Organic Chemistry
Published
This submission belongs to the session a. General Organic Synthesis of the event The 20th International Electronic Conference on Synthetic Organic Chemistry
Published date
01 Nov, 2016
Citation
Antonio Franconetti, María Pérez-Martín, Pastora Borrachero, Francisca Cabrera-Escribano, Exploring synthetic ureidyl carbohydrates for potential human adenovirus inhibition, in Proceedings of The 20th International Electronic Conference on Synthetic Organic Chemistry, 1 November–30 November 2016, MDPI: Basel, Switzerland, doi: 10.3390/ecsoc-20-a011
Share
Email
Facebook
Twitter
LinkedIn

Exploring synthetic ureidyl carbohydrates for potential human adenovirus inhibition

image
María Pérez-Martín 1
Pastora Borrachero 1
1. Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Spain
Abstract

Adenoviruses (Ads) are common pathogens in patients with compromised immunity being a potentially life-threatening disease. Human Ads are usually associated with respiratory infections, gastroenteritis or viral conjunctivitis among others pathologies with significant clinical impact.

Pharmacological approach for the treatment of these Ads involves several targets such as DNA polymerase, coxsackievirus and adenovirus receptor or human adenovirus proteinase (AVP). Recently, privileged structures based on piperazin-2-one have been used as effective molecules for Ad DNA replication through unknown mechanism so far.

Herein, we report an easy synthesis of both mono and disaccharides ureidyl-glucosamine derivatives in good yields, that mimic a feasible interaction with active sites of Ad proteinase. All new compounds were characterised by means of 1H, 13C NMR as well as mass spectrometry. Finally, a biological screening for synthesized compounds on human epithelial cell was carried out. 

 

Keywords
Manuscript
Microwave-assisted Facile Synthesis And Anticancer Evaluation Of N-((5-(substituted Methylene Amino)- 1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives
Metal-organic frameworks as an appropriate platform for controlled drug release